Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth factor receptor inhibitors: An assessment of topical timolol and the need for multiple medical and procedural therapies. uri icon

Overview

publication date

  • June 11, 2020

Research

keywords

  • Adrenergic beta-Antagonists
  • Angiolymphoid Hyperplasia with Eosinophilia
  • Antineoplastic Combined Chemotherapy Protocols
  • Paronychia
  • Timolol

Identity

Scopus Document Identifier

  • 85088834020

Digital Object Identifier (DOI)

  • 10.1016/j.jaad.2020.06.010

PubMed ID

  • 32526318

Additional Document Info

volume

  • 84

issue

  • 3